Here, we present a protocol for using polysaccharide hemostatic materials to manage hemorrhage after endoscopic submucosal dissection (ESD).
Method Article
* These authors contributed equally
Here, we present a protocol for using polysaccharide hemostatic materials to manage hemorrhage after endoscopic submucosal dissection (ESD).
Endoscopic submucosal dissection (ESD) is a minimally invasive procedure that is widely used for the treatment of early gastric cancer and certain submucosal tumors. ESD often results in large artificial ulcers, leading to a risk of intraoperative and postoperative bleeding, which is a significant complication. Traditional methods to address this bleeding include proton pump inhibitors (PPIs), local hemostatic sprays, hemostatic clips, electrocoagulation, etc. However, this research introduces polysaccharide-based materials as a novel hemostatic solution, demonstrating their effectiveness in preventing upper gastrointestinal tract bleeding associated with ESD. The results of our study, focusing on both gastric and esophageal lesions, suggest that the microporous polysaccharide hemostatic material is effective in preventing bleeding following upper gastrointestinal tract ESD procedures. The key benefits of polysaccharide hemostatic materials include biocompatibility, no immune risk, excellent absorbability, and fast hemostatic speed. Clinical results from the study indicate that patients treated with these materials did not experience delayed bleeding, and follow-up gastroscopy showed good wound healing without negative impacts on the artificial ulcer. This suggests that polysaccharide hemostatic materials are a safe and effective option for patients undergoing gastric ESD surgery.
With the development of endoscopic technology, ESD has been widely used in the minimally invasive treatment of early gastric cancer and submucosal tumors1. This technology can completely remove large areas of lesions and has a low residual and recurrence rate2. The main complications of gastric ESD surgery include perforation, bleeding, infection, and stenosis3. Among them, delayed bleeding after ESD surgery is considered one of the most serious and challenging complications of ESD4. Despite the use of preventive measures like proton pump inhibitors (PPIs), intraoperative e....
Access restricted. Please log in or start a trial to view this content.
This study was approved by the Shanghai Civil Aviation Hospital Committee (Ethics Approval No: 2023-06), and written informed consent was obtained from all participants prior to their inclusion in the study.
1. Preoperative preparation
2. Gastroscop....
Access restricted. Please log in or start a trial to view this content.
On May 2024, 5 patients undergoing esophageal and gastric mucosal ESD surgery received polysaccharide hemostatic materials for local hemostasis of wounds (Table 1). In this study, 1 g of microporous polysaccharide hemostatic material was uniformly applied to each ulcer. However, for ulcers located in the cardia, 2 g of the material was used, due to the abundant blood vessels in this region. Every esophageal and gastric mucosal lesion diagnosis was confirmed through pathological examination. None were con.......
Access restricted. Please log in or start a trial to view this content.
Although endoscopic submucosal dissection (ESD) is considered a relatively safe treatment method, it is not without potential risks and complications3. These include bleeding, perforation, infection, anesthesia-related risks, postoperative pain, etc3. Bleeding is a particularly significant concern, especially in cases involving large or deeply located tumors4. Postoperative bleeding is most likely to occur within 24 h after surgery, although it can a.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This work was supported by the Scientific research project of Health and Wellness Committee Changning District Shanghai (No. 2023QN30; No. 20214Y050), the Scientific research project of Health and Wellness Committee Changning District Shanghai (No. 20233010) and the Foundation of Shanghai Civil Aviation Hospital Project (No. 2024mhyk001).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Argon electrode | ERBE Elektromedizin GmbH | 20132-177 | |
| Digestive endoscopy argon plasma coagulation (APC) knife system | ERBE Elektromedizin GmbH | VIO200 | |
| Disposable high-frequency cutting knife | Micro-Tech (Nanjing) CO, Ltd | MK-T-2-195 | |
| Endoscopic therapy device | Fujifilm (China) Investment Co., Ltd | BL-7000 | |
| Gastroscope | Fujifilm (China) Investment Co., Ltd | EG-760CT | |
| Hot biopsy forceps | Nanwei Medical Technology Co., Ltd | N/A | |
| Petroleum jelly | Qingdao Jinqi Biotechnology Co., Ltd | N/A | |
| Polysaccharide hemostatic powder | Jiangsu Deviceland Medical Devices Co., LTD | N/A | |
| Powder dispenser | Jiangsu Deviceland Medical Devices Co., LTD | N/A |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission